Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
Int. braz. j. urol ; 40(2): 257-265, Mar-Apr/2014. graf
Artigo em Inglês | LILACS | ID: lil-711695

RESUMO

PurposeTo evaluate the synthesis of type I (mature) and type III (immature) collagen in bladder suture of rats treated with a combination of tacrolimus and mycophenolate mofetil for 15 days.Materials and MethodsThirty rats were divided into 3 groups: the sham, control and experimental groups. All the animals underwent laparotomy, cystotomy and bladder suture in two planes with surgical PDS 5-0 thread. The sham group did not receive treatment. The control group received saline solution, and the experimental group received 0.1mg/kg/day of tacrolimus with 20mg/kg/day of mycophenolate mofetil, for 15 days. From then on, the tacrolimus was dosed. The surgical specimens of the bladder suture area were processed so that the total type I and type III collagen could be measured by the picrosirius red technique.ResultsThere was a predominance of type I collagen production in the sham and control groups compared to the experimental group, in which type III collagen was predominant. The production of total collagen did not change.ConclusionThe association of tacrolimus and mycophenolate mofetil in animals qualitatively changes the production of collagen after 15 days with a predominance of type III collagen.


Assuntos
Animais , Colágeno Tipo I/biossíntese , Colágeno Tipo III/biossíntese , Imunossupressores/uso terapêutico , Ácido Micofenólico/análogos & derivados , Suturas , Tacrolimo/uso terapêutico , Bexiga Urinária/cirurgia , Colágeno Tipo I/efeitos dos fármacos , Colágeno Tipo III/efeitos dos fármacos , Ácido Micofenólico/uso terapêutico , Ratos Wistar , Reprodutibilidade dos Testes , Técnicas de Sutura , Resultado do Tratamento , Cicatrização/efeitos dos fármacos
2.
Journal of Korean Medical Science ; : 82-87, 2005.
Artigo em Inglês | WPRIM | ID: wpr-110316

RESUMO

Complete or partial triplication of human chromosome 21 results in Down syndrome (DS). To analyze differential gene expressions in amniotic fluid (AF) cells of DS, we used a DNA microarray system to analyze 102 genes, which included 24 genes on chromosome 21, 28 genes related to the function of brain and muscle, 36 genes related to apoptosis, 4 genes related to extracellular matrix, 8 genes related to other molecular function and 2 house-keeping genes. AF cells were collected from 12 pregnancies at 16-18 weeks of gestation in DS (n=6) and normal (n=6) subjects. Our DNA microarray experiments showed that the expressions of 11 genes were altered by at least 2-folds in DS, as follows. Ten genes, COL6A1, CASP5, AKT2, JUN, PYGM, BNIP1, OSF-2, PRSS7, COL3A1, and MBLL were down-regulated and GSTT1 was only up-regulated. The differential expressions of GSTT1 and COL3A1 were further confirmed by semi-quantitative RT-PCR for each sample. The gene dosage hypothesis on chromosome 21 may explain the neurological and other symptoms of DS. However, our results showed that only two genes (COL6A1 and PRSS7), among 24 genes on chromosome 21, were down-regulated in the AF cells of DS. Our data may provide the basis for a more systematic identification of biological markers of fetal DS, thus leading to an improved understanding of pathogenesis for fetal DS.


Assuntos
Humanos , Amniocentese , Líquido Amniótico/citologia , Apoptose , Células Cultivadas , Cromossomos Humanos Par 21 , Colágeno Tipo III/biossíntese , DNA Complementar/metabolismo , Síndrome de Down/genética , Regulação para Baixo , Dosagem de Genes , Expressão Gênica , Regulação da Expressão Gênica , Glutationa Transferase/biossíntese , Modelos Genéticos , Análise de Sequência com Séries de Oligonucleotídeos , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Fatores de Tempo , Regulação para Cima
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA